Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Cadila Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011797
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cadila Pharmaceuticals Ltd (Cadila Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The company’s products include active pharmaceutical ingredients (API) and pharmaceutical formulations. Its business includes contract research operation, contract manufacturing, herbal and agro divison. Cadila Pharmaceuticals products are used in the therapeutic areas of gastrointestinal, cardiovascular, anti-infectives and antibiotics, analgesics, haematinics, respiratory agents, immunologicals, oncology and antidiabetics, among others. The company’s products are in the form of capsules, tablets, orals, soft and hard gelatin capsules, and liquids. It has operations in Kenya, Nigeria, Ethiopia, the UK, Russia, the US, Sweden and Japan. Cadila Pharmaceuticals is headquartered in Ahmedabad, Gujarat, India.

Cadila Pharmaceuticals Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cadila Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Aplagon Enters into Agreement with Cadila Pharma Sweden 11
Oncology Venture Enters into Co-Development Agreement with Cadila Pharma 12
Lipidor Enters into Agreement with Cadila Pharma 13
Axelar Enters into Co-Development Agreement with Cadila Pharma 14
Cadila Pharma Enters into Agreement with Respiratorius 15
NovaSAID Enters Into Co-Development Agreement With Cadila Pharma 16
Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 17
Licensing Agreements 18
Cadila Pharma and Altus Formulation Enter into Agreement 18
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 19
Cadila Pharma Enters Into Licensing Agreement With Helperby Therapeutics 20
Cadila Pharmaceuticals Ltd – Key Competitors 21
Cadila Pharmaceuticals Ltd – Key Employees 22
Cadila Pharmaceuticals Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Legal and Regulatory 25
Sep 02, 2016: Cadila Healthcare Receives Establishment Inspection Report For Ahmedabad 25
Aug 16, 2016: Cadila Healthcare provides Operational Update 26
Aug 16, 2016: Cadila Healthcare Receives Establishment Inspection Report For Changodar Facility 27
Other Significant Developments 28
Mar 22, 2016: Cadila Healthcare: Corporate Announcement 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cadila Pharmaceuticals Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Cadila Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Cadila Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aplagon Enters into Agreement with Cadila Pharma Sweden 11
Oncology Venture Enters into Co-Development Agreement with Cadila Pharma 12
Lipidor Enters into Agreement with Cadila Pharma 13
Axelar Enters into Co-Development Agreement with Cadila Pharma 14
Cadila Pharma Enters into Agreement with Respiratorius 15
NovaSAID Enters Into Co-Development Agreement With Cadila Pharma 16
Pergamum And Cadila Pharma Partner To Develop Novel Antibiotics For Infections 17
Cadila Pharma and Altus Formulation Enter into Agreement 18
Cadila Pharma Enters into Licensing Agreement with Moberg Pharma 19
Cadila Pharma Enters Into Licensing Agreement With Helperby Therapeutics 20
Cadila Pharmaceuticals Ltd, Key Competitors 21
Cadila Pharmaceuticals Ltd, Key Employees 22
Cadila Pharmaceuticals Ltd, Other Locations 23
Cadila Pharmaceuticals Ltd, Subsidiaries 23
Cadila Pharmaceuticals Ltd, Joint Venture 24

★海外企業調査レポート[Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Higherway Electronic Co., Ltd. (3268):企業の財務及び戦略的SWOT分析
    Summary Higherway Electronic Co., Ltd. (Higherway) is an electronic equipment manufacturer that designs, integrates program, and markets integrated circuit applications. The company offers products such as electronic learning aids, LCD, multi channel music synthesizer, multimedia, optical product, a …
  • Delta Air Lines, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Delta Air Lines, Inc. Mergers a …
  • Trion Worlds, Inc. (formerly Trion World Network, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Trion Worlds, Inc. (formerly Tr …
  • Nahar Capital & Financial Services Ltd. (NAHARCAP):企業財務及び戦略的SWOT分析
    Summary Nahar Capital & Financial Services Ltd. (NCFSL) is a non-banking finance company that provides investment and financial services. The company’s business activities comprise invests in shares, debentures, stock, bonds and securities, banks, mutual funds and any authority. It also invests in p …
  • Ivy Cosmetics Corporation:企業の戦略・SWOT・財務分析
    SummaryIvy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Helius Medical Technologies, Inc. (HSDT):企業のM&A・提携動向(医療機器分野)
    Summary Helius Medical Technologies, Inc. (HMT) is a medical technology company that concentrates on neurological wellness. The company develops, licenses and acquires unique and non-invasive platform technologies for amplifying the brain’s ability to heal itself. It is into developing technology as …
  • Multi-Color Corporation (LABL):企業の財務及び戦略的SWOT分析
    Summary Multi-Color Corporation (Multi-Color) is a global label manufacturer that produces packaging labels. The company's products include cut and stack labels, heat transfer labels, in-mold label, pressure sensitive labels, shrink sleeve labels, and others. Its printing technologies include rotogr …
  • Oceaneering International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Oceaneering International, Inc. …
  • Stork Aerospace Services:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Stork Aerospace Services Merger …
  • BG Medicine, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BG Medicine, Inc. Mergers and A …
  • Pfizer Limited, India (PFIZER):企業概要、財務及び戦略的SWOT分析
    Summary Pfizer Limited, India (Pfizer India) is a pharmaceutical company. The company develops medicines for humans and animals. Its products include anti-allergic, anti-diabetic, antihistamine, anti-infectives, anti-parasitic, cardiovascular, dermatology, erectile dysfunction, GI, multivitamins, ne …
  • Strategic Oil & Gas, Ltd. (SOG):企業の財務及び戦略的SWOT分析
    Summary Strategic Oil & Gas, Ltd. (Strategic) is an oil and gas exploration company that explores and develops activities for crude oil and natural gas. The company exploits light oil assets in Maxhamish, northeast British Columbia, Marlowe located in Northwestern Alberta and Cameron Hills is locate …
  • G-III Apparel Group, Ltd. (GIII):企業の財務及び戦略的SWOT分析
    Summary G-III Apparel Group, Ltd. (G-III) is a consumer product company that offers apparels. The company manufactures and distributes outerwear, dresses, sportswear, beachwear and women suits among others. It offers products through divisions such as outerwear, ready to wear, dresses, team sports, …
  • Prosensa Therapeutics B.V.(製薬・医療分野):企業M&A動向
    Summary Prosensa Therapeutics B.V. (Prosensa) is a biotechnology company. The company discovers, develops and commercializes RNA modulating therapeutics. Its focus is on three Neuromuscular Disorders, namely, Duchenne Muscular Dystrophy(DMD), Myotonic Dystrophy(DM1) and Huntington’s disease(HD). Pro …
  • Semcon AB (SEMC):企業財務及び戦略的SWOT分析
    Summary Semcon AB (Semcon) is an engineering company that offers product design and information services. The company offers services such as production development, project management, designing, product development, and product information. Its designing services comprise visualization, industrial …
  • Oxford Instruments Plc (OXIG):企業財務及び戦略的SWOT分析
    Oxford Instruments Plc (OXIG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Halt Medical, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Halt Medical, Inc. (Halt Medical) is a pharmaceutical company that designs, develops, manufactures, markets, and commercializes medical treatment and devices. The company offers Acessa system and procedure for the treatment of women suffering with symptomatic uterine fibroids. It offers serv …
  • NeuroVive Pharmaceutical AB (NVP):企業財務及び戦略的SWOT分析
    Summary NeuroVive Pharmaceutical AB (NeuroVive), formerly Neuro Pharma is a pharmaceutical company that research and develops pharmaceuticals to protect mitochondria from post acute traumatic injury. The company’s drug development technology platform comprises cyclosporine-A for the treatment of acu …
  • Sterling Bancorp:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sterling Bancorp Mergers and Ac …
  • Volcano Corp:企業のM&A・提携動向(医療機器分野)
    Summary Volcano Corp (Volcano), a subsidiary of Koninklijke Philips NV is a medical device company that develops, manufactures and commercializes therapy products such as intravascular ultrasound and fractional flow reserve products. The company’s products include IVUS imaging, platinum catheter, sh …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆